(Q51603232)

English

Evaluation of the accuracy of serum human epididymis protein 4 in combination with CA125 for detecting ovarian cancer: a prospective case-control study in a Korean population.

scientific article published on 15 February 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/21320028

Evaluation of the accuracy of serum human epididymis protein 4 in combination with CA125 for detecting ovarian cancer: a prospective case-control study in a Korean population. (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/21320028

1 reference

based on heuristic

inferred from title

author name string

Yong Man Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/21320028

Dong Hee Whang

2

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/21320028

Joonseok Park

3

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/21320028

Sung Hoon Kim

4

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/21320028

Shin Wha Lee

5

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/21320028

Hyun Ah Park

6

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/21320028

Mina Ha

7

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/21320028

Kyung-Hwa Choi

8

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/21320028

publication date

15 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/21320028

Clinical Chemistry and Laboratory Medicine

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/21320028

49

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/21320028

3

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/21320028

527-534

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/21320028

Cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.085

21 January 2018

Estimates of the worldwide incidence of 25 major cancers in 1990.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.085

21 January 2018

Minimizing delays in ovarian cancer diagnosis: an expansion of Andersen's model of 'total patient delay'.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.085

21 January 2018

Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.085

21 January 2018

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.085

21 January 2018

Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.085

21 January 2018

Development of a multimarker assay for early detection of ovarian cancer

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.085

21 January 2018

The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.085

21 January 2018

Potential markers that complement expression of CA125 in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.085

21 January 2018

Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.085

21 January 2018

Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.085

21 January 2018

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.085

21 January 2018

Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.085

21 January 2018

Ovarian cancer incidence and survival in Korea: 1993-2002

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.085

21 January 2018

Identifiers

10.1515/CCLM.2011.085

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/21320028

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/21320028

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51603232&oldid=1234892353"